About: http://data.cimple.eu/news-article/f2f421c44bb535dea396b13d88d711466eda0aacca82712b13a48b57

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/f2f421c44bb535dea396b13d88d711466eda0aacca82712b13a48b57 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Antibiotic resistance has the potential to cause a global health crisis far worse than COVID-19, a group of global pharmaceutical companies warned Thursday as they ploughed one billion dollars into research to combat the issue. The 20 companies supporting the project, including industry giants Pfizer, Roche and Bayer, hope to bring up to four new antibiotics to the market by 2030, the IFPMA association of pharmaceutical companies said in a statement. "Antimicrobial resistance (AMR) is a looming global crisis that has the potential to dwarf COVID-19 in terms of deaths and economic costs," the IFPMA said. There are currently few new antibiotics in the pipeline because there is no viable market for them, the association said. Resistance to antibiotics has grown in recent years due to overuse in humans, but also in farm animals. New antibiotics are used sparingly to preserve effectiveness, leading many companies to stop investing in them due to the lack of commercial sustainability. The fund will invest in small companies developing antibacterial treatments and will also work with charities, development banks, governments and other organisations. The antibiotics discovered "could be marketed by these companies, or in partnership with one of the participating groups," IFPMA director-general Thomas Cueni told AFP. Around 700,000 people die around the world every year as a result of antibiotic resistance, the IFPMA said. According to a British study, antibiotic-resistant bacteria could kill up to 10 million people a year by 2050. fec/hmn/jh
schema:headline	Pharma giants invest $1 bn in antibiotic research
schema:mentions	Global health Antimicrobial resistance Thomas Wayne Bayer Hoffmann-La Roche Agence France-Presse Pharmaceutical industry Antibiotic Pipeline transport Pfizer United Kingdom Coronavirus disease 2019 AMR Corporation Industry Giants International Federation of Pharmaceutical Manufacturers & Associations
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-07-09 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	85 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software